84 related articles for article (PubMed ID: 8531377)
1. [Lymphoproliferative disorders in patients with Sjögren's syndrome--Vg gene rearrangement and expression of bcl-2 protein].
Sugai S; Takeshita S; Ogawa Y; Masaki Y; Doumiki T; Takeuchi Y
Nihon Rinsho; 1995 Oct; 53(10):2580-6. PubMed ID: 8531377
[TBL] [Abstract][Full Text] [Related]
2. Rearrangement of the rheumatoid factor-related germline gene Vg and bcl-2 expression in lymphoproliferative disorders in patients with Sjögren's syndrome.
Sugai S; Saito I; Masaki Y; Takeshita S; Shimizu S; Tachibana J; Miyasaka N
Clin Immunol Immunopathol; 1994 Aug; 72(2):181-6. PubMed ID: 8050191
[TBL] [Abstract][Full Text] [Related]
3. [Sjögren's syndrome as a lymphoaggressive disorder; bcl-2 expression in lymphocytes infiltrated in salivary glands].
Takeshita S; Sugai S
Nihon Rinsho; 1995 Oct; 53(10):2440-5. PubMed ID: 8531352
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative disorders in Japanese patients with Sjögren's syndrome.
Sugai S; Shimizu S; Konda S
Scand J Rheumatol Suppl; 1986; 61():118-22. PubMed ID: 3473620
[TBL] [Abstract][Full Text] [Related]
5. Lymphoproliferative disorders in Sjögren's syndrome.
Masaki Y; Sugai S
Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
Nakamura H; Kawakami A; Tominaga M; Migita K; Kawabe Y; Nakamura T; Eguchi K
Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjögren's syndrome.
Pivetta B; De Vita S; Ferraccioli G; De Re V; Gloghini A; Marzotto A; Caruso G; Dolcetti R; Bartoli E; Carbone A; Boiocchi M
J Rheumatol; 1999 May; 26(5):1101-9. PubMed ID: 10332975
[TBL] [Abstract][Full Text] [Related]
8. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
Nagai K
Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
[TBL] [Abstract][Full Text] [Related]
9. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
Ioannidis JP; Vassiliou VA; Moutsopoulos HM
Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410
[TBL] [Abstract][Full Text] [Related]
10. Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach.
De Vita S; De Marchi G; Sacco S; Gremese E; Fabris M; Ferraccioli G
Blood Cells Mol Dis; 2001; 27(4):757-66. PubMed ID: 11778660
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
[TBL] [Abstract][Full Text] [Related]
12. [Malignancy in autoimmune diseases].
Sugai S
Nihon Rinsho Meneki Gakkai Kaishi; 1996 Feb; 19(1):1-14. PubMed ID: 8681020
[TBL] [Abstract][Full Text] [Related]
13. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
[TBL] [Abstract][Full Text] [Related]
14. [Sjogren's syndrome and lymphoproliferative lesions].
Sugai S
Nihon Naika Gakkai Zasshi; 2000 Sep; 89(9):1948-56. PubMed ID: 11051677
[No Abstract] [Full Text] [Related]
15. [Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease].
Vasil'ev VI; Probatova NA; Varlamova EIu; Tupitsin NN; Simonova MV; Safonova TN; Bozh'eva LA; Shornikova NS; Logvinenko OA; Belenin GIu
Ter Arkh; 2004; 76(8):61-8. PubMed ID: 15471400
[TBL] [Abstract][Full Text] [Related]
16. [Clinical aspects and types of Sjögren's syndrome].
Sugai S; Takeshita S; Ogawa Y; Fukutoku M; Masaki Y
Nihon Rinsho; 1995 Oct; 53(10):2376-82. PubMed ID: 8531341
[TBL] [Abstract][Full Text] [Related]
17. Secondary tumours in Sjögren's syndrome.
Kovács L; Szodoray P; Kiss E
Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
[TBL] [Abstract][Full Text] [Related]
18. Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome.
Fox RI; Chen P; Carson DA; Fong S
J Immunol; 1986 Jan; 136(2):477-83. PubMed ID: 3079786
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
Tapinos NI; Polihronis M; Moutsopoulos HM
Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
[TBL] [Abstract][Full Text] [Related]
20. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
